Invetx - Crunchbase Company Profile & Funding

Q: Where is Invetx's headquarters?

Invetx is located in Boston, Massachusetts, United States.

Q: Who invested in Invetx?

Invetx has 9 investors including Eight Roads Ventures And Tekla Capital Management.

Q: When was the last funding round for Invetx?

Invetx closed its last funding round on obfuscated from a Series B round.

Overview

Invetx

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Invetx

CB Rank

36402

Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.

Acquired by

Dechra Pharmaceuticals

Founded

obfuscation

Private

Series B

Boston, Massachusetts, United States

11-50

www.invetx.com

Biopharma

Biotechnology

Veterinary

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Bill Brondyk: Chief Scientific Officer
Colin Giles: Chief Development Officer
Past Role: Zoetis, Vice President for Veterinary Medicine Pharmaceuticals R&D

Details

Legal Name

Invetx, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Juergen Horn

About the Company

Invetx is a veterinary therapeutics company that develops protein-based therapeutics for animal health. Invetx's network includes animal and human health experts, veterinary scientists, and clinicians. The company's vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved

health outcomes for pets and farm animal populations.

Contact Email

info@invetx.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Antibody Discovery Platform

A platform that integrates technologies for discovering and developing species-specific monoclonal antibodies for veterinary use.

Half-Life Extension Technology Platform

A proprietary technology that extends the duration of monoclonal antibody treatments in dogs and cats.

Research & Development

Invetx is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Invetx	7	obfuscated obfuscation	Eight Roads Ventures, F-Prime, Google Ventures, Novo Holdings	Series B
obfuscated obfuscation	Series B - Invetx	7	obfuscated obfuscation	Eight Roads Ventures, F-Prime, Google Ventures, Novo Holdings	Series B
obfuscated obfuscation	Series B - Invetx	7	obfuscated obfuscation	Eight Roads Ventures, F-Prime, Google Ventures, Novo Holdings	Series B
obfuscated obfuscation	Series B - Invetx	7	obfuscated obfuscation	Eight Roads Ventures, F-Prime, Google Ventures, Novo Holdings	Series B
obfuscated obfuscation	Series B - Invetx	7	obfuscated obfuscation	Eight Roads Ventures, F-Prime, Google Ventures, Novo Holdings	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Invetx	7	obfuscated obfuscation	Eight Roads Ventures, F-Prime, Google Ventures, Novo Holdings	Series B
obfuscated obfuscation	Series B - Invetx	7	obfuscated obfuscation	Eight Roads Ventures, F-Prime, Google Ventures, Novo Holdings	Series B
obfuscated obfuscation	Series B - Invetx	7	obfuscated obfuscation	Eight Roads Ventures, F-Prime, Google Ventures, Novo Holdings	Series B
obfuscated obfuscation	Series B - Invetx	7	obfuscated obfuscation	Eight Roads Ventures, F-Prime, Google Ventures, Novo Holdings	Series B
obfuscated obfuscation	Series B - Invetx	7	obfuscated obfuscation	Eight Roads Ventures, F-Prime, Google Ventures, Novo Holdings	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Eight Roads Ventures	Yes	Series B - Invetx	—
Eight Roads Ventures	Yes	Series B - Invetx	—
Eight Roads Ventures	Yes	Series B - Invetx	—
Eight Roads Ventures	Yes	Series B - Invetx	—
Eight Roads Ventures	Yes	Series B - Invetx	—